MEGX

• CAT Number: I012487
• CAS Number: 7728-40-7
• Molecular Formula: C12H18N2O
• Molecular Weight: 206.29
• Purity: ≥95%
• Synonyms: Monoethylglycinexylidide; N-(2,6-Dimethylphenyl)-2-(ethylamino)acetamide hydrochloride
• IUPAC Name: N-(2,6-dimethylphenyl)-2-(ethylamino)acetamide
• InChI: InChI=1S/C12H18N2O/c1-4-13-8-11(15)14-12-9(2)6-5-7-10(12)3/h5-7,13H,4,8H2,1-3H3,(H,14,15)
• InChIKey: WRMRXPASUROZGT-UHFFFAOYSA-N
• SMILES: CCNCC(=O)NC1=C(C=CC=C1C)C

MEGX (Monoethylglycinexylidide)(CAT: I012487) is an active metabolite of lidocaine, commonly used as a biomarker in liver function studies. It is produced through hepatic metabolism by cytochrome P450 enzymes, making it valuable for assessing liver enzyme activity and drug metabolism efficiency. MEGX is widely employed in pharmacokinetic research and clinical diagnostics to evaluate hepatic health and function, particularly in cases of liver impairment or drug-induced toxicity. With high purity and stability, MEGX is suitable for in vitro and in vivo studies, supporting advanced research in pharmacology, toxicology, and liver disease evaluation.